RNA Interference Knockdown of DNA Methyl- Transferase 3 Affects Gene Alternative Splicing in the Honey Bee
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Multivariate Genome-Wide Association Study of Wing Shape in Drosophila Melanogaster William Pitchers1#A, Jessica Nye2#B, Eladio J
Genetics: Early Online, published on February 21, 2019 as 10.1534/genetics.118.301342 A multivariate genome-wide association study of wing shape in Drosophila melanogaster William Pitchers1#a, Jessica Nye2#b, Eladio J. Márquez2#c, Alycia Kowalski1, Ian Dworkin1*#d, David Houle2* 1 Affiliation: Department of Integrative Biology, Program in Ecology, Evolutionary Biology and Behavior, Michigan State University, East Lansing, Michigan, United States of America 2 Affiliation: Department of Biological Science, Florida State University, Tallahassee, Florida, United States of America #aCurrent Addresss: Microbiological Diagnostic Unit Public Health Laboratory at the University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. #b Current Address: Centre for Research in Agricultural Genomics (CRAG) CSIC-IRTA- UAB-UB, Barcelona, 08193, Spain. #cCurrent Address: The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, Connecticut, United States of America. #dCurrent Address: Department of Biology, McMaster University, Hamilton Ontario, Canada *Authors for correspondence, e-mail: [email protected] & [email protected] Running title: Multivariate GWAS of the fly wing Keywords: Multivariate GWAS, genome-wide association analysis, developmental genetics, phenomics, GP map, Drosophila wing Copyright 2019. Article Summary Understanding the inheritance and evolution of complex traits is an important challenge to geneticists and evolutionary biologists alike. A detailed understanding of how genetic variation affects complex traits is important for the treatment of disease, for our attempts to control the evolution of useful or dangerous organisms, and for understanding and predicting evolution over long time scales. To help understand the evolution and development of the Drosophila melanogaster wing, a model complex trait, we undertook a multivariate genome-wide association study using the Drosophila Genome Reference Panel. -
RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases
G C A T T A C G G C A T genes Review RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases Amber Willbanks, Shaun Wood and Jason X. Cheng * Department of Pathology, Hematopathology Section, University of Chicago, Chicago, IL 60637, USA; [email protected] (A.W.); [email protected] (S.W.) * Correspondence: [email protected] Abstract: Chromatin structure plays an essential role in eukaryotic gene expression and cell identity. Traditionally, DNA and histone modifications have been the focus of chromatin regulation; however, recent molecular and imaging studies have revealed an intimate connection between RNA epigenetics and chromatin structure. Accumulating evidence suggests that RNA serves as the interplay between chromatin and the transcription and splicing machineries within the cell. Additionally, epigenetic modifications of nascent RNAs fine-tune these interactions to regulate gene expression at the co- and post-transcriptional levels in normal cell development and human diseases. This review will provide an overview of recent advances in the emerging field of RNA epigenetics, specifically the role of RNA modifications and RNA modifying proteins in chromatin remodeling, transcription activation and RNA processing, as well as translational implications in human diseases. Keywords: 5’ cap (5’ cap); 7-methylguanosine (m7G); R-loops; N6-methyladenosine (m6A); RNA editing; A-to-I; C-to-U; 2’-O-methylation (Nm); 5-methylcytosine (m5C); NOL1/NOP2/sun domain Citation: Willbanks, A.; Wood, S.; (NSUN); MYC Cheng, J.X. RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases. Genes 2021, 12, 627. -
RNA Interference with Sirna
CANCER GENOMICS & PROTEOMICS 3: 127-136 (2006) Review RNA Interference with siRNA HELENA JOYCE*, ISABELLA BRAY* and MARTIN CLYNES National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland Abstract. Over the last decade, RNA interference has RNAs (13). Twenty-one different gene products with emerged as an effective mechanism for silencing gene different functions and subcellular localizations were expression. This ancient cellular antiviral response can be used studied. Knockdown experiments, monitored by to allow specific inhibition of the function of any chosen target immunofluorescence and immunoblotting, showed that even gene, including those involved in diseases such as cancer, major cellular proteins such as actin and vimentin could be AIDS and hepatitis. It has become an invaluable research tool silenced efficiently. Previous work had discovered that these to aid in the identification of novel genes involved in disease 22-nucleotide sequences served as guide sequences that processes. It has advanced from the use of synthetic RNA for instruct a multicomponent nuclease, RNA-induced silencing the endogenous production of small hairpin RNA by plasmid complex (RISC), to destroy specific messenger RNAs (7). and viral vectors, and from transient inhibition in vitro to It was then found that, in response to dsRNA, cells trigger longer-lasting effects in vivo. However, as with antisense and a two-step reaction. In the first step, long dsRNA is ribozymes, the efficient delivery of siRNA into cells is currently processed by a ribonuclease (RNase) III enzyme, called the limiting factor to successful gene expression inhibition in Dicer, into small interfering RNAs (siRNAs); these vivo. This review gives an overview of the mechanism of action subsequently serve as the sequence determinants of the of siRNA and its use in cancer research. -
RNA Interference in the Nucleus: Roles for Small Rnas in Transcription, Epigenetics and Beyond
REVIEWS NON-CODING RNA RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond Stephane E. Castel1 and Robert A. Martienssen1,2 Abstract | A growing number of functions are emerging for RNA interference (RNAi) in the nucleus, in addition to well-characterized roles in post-transcriptional gene silencing in the cytoplasm. Epigenetic modifications directed by small RNAs have been shown to cause transcriptional repression in plants, fungi and animals. Additionally, increasing evidence indicates that RNAi regulates transcription through interaction with transcriptional machinery. Nuclear small RNAs include small interfering RNAs (siRNAs) and PIWI-interacting RNAs (piRNAs) and are implicated in nuclear processes such as transposon regulation, heterochromatin formation, developmental gene regulation and genome stability. RNA interference Since the discovery that double-stranded RNAs (dsRNAs) have revealed a conserved nuclear role for RNAi in (RNAi). Silencing at both the can robustly silence genes in Caenorhabditis elegans and transcriptional gene silencing (TGS). Because it occurs post-transcriptional and plants, RNA interference (RNAi) has become a new para- in the germ line, TGS can lead to transgenerational transcriptional levels that is digm for understanding gene regulation. The mecha- inheritance in the absence of the initiating RNA, but directed by small RNA molecules. nism is well-conserved across model organisms and it is dependent on endogenously produced small RNA. uses short antisense RNA to inhibit translation or to Such epigenetic inheritance is familiar in plants but has Post-transcriptional gene degrade cytoplasmic mRNA by post-transcriptional gene only recently been described in metazoans. silencing silencing (PTGS). PTGS protects against viral infection, In this Review, we cover the broad range of nuclear (PTGS). -
RNA-Based Technologies for Engineering Plant Virus Resistance
plants Review RNA-Based Technologies for Engineering Plant Virus Resistance Michael Taliansky 1,2,*, Viktoria Samarskaya 1, Sergey K. Zavriev 1 , Igor Fesenko 1 , Natalia O. Kalinina 1,3 and Andrew J. Love 2,* 1 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia; [email protected] (V.S.); [email protected] (S.K.Z.); [email protected] (I.F.); [email protected] (N.O.K.) 2 The James Hutton Institute, Invergowrie, Dundee DD2 5DA, UK 3 Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory, 119991 Moscow, Russia * Correspondence: [email protected] (M.T.); [email protected] (A.J.L.) Abstract: In recent years, non-coding RNAs (ncRNAs) have gained unprecedented attention as new and crucial players in the regulation of numerous cellular processes and disease responses. In this review, we describe how diverse ncRNAs, including both small RNAs and long ncRNAs, may be used to engineer resistance against plant viruses. We discuss how double-stranded RNAs and small RNAs, such as artificial microRNAs and trans-acting small interfering RNAs, either produced in transgenic plants or delivered exogenously to non-transgenic plants, may constitute powerful RNA interference (RNAi)-based technology that can be exploited to control plant viruses. Additionally, we describe how RNA guided CRISPR-CAS gene-editing systems have been deployed to inhibit plant virus infections, and we provide a comparative analysis of RNAi approaches and CRISPR-Cas technology. The two main strategies for engineering virus resistance are also discussed, including direct targeting of viral DNA or RNA, or inactivation of plant host susceptibility genes. -
RNA Interference in the Age of CRISPR: Will CRISPR Interfere with Rnai?
International Journal of Molecular Sciences Review RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi? Unnikrishnan Unniyampurath 1, Rajendra Pilankatta 2 and Manoj N. Krishnan 1,* 1 Program on Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore; [email protected] 2 Department of Biochemistry and Molecular Biology, School of Biological Sciences, Central University of Kerala, Nileshwar 671328, India; [email protected] * Correspondence: [email protected]; Tel.: +65-6516-2666 Academic Editor: Michael Ladomery Received: 2 November 2015; Accepted: 15 February 2016; Published: 26 February 2016 Abstract: The recent emergence of multiple technologies for modifying gene structure has revolutionized mammalian biomedical research and enhanced the promises of gene therapy. Over the past decade, RNA interference (RNAi) based technologies widely dominated various research applications involving experimental modulation of gene expression at the post-transcriptional level. Recently, a new gene editing technology, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and the CRISPR-associated protein 9 (Cas9) (CRISPR/Cas9) system, has received unprecedented acceptance in the scientific community for a variety of genetic applications. Unlike RNAi, the CRISPR/Cas9 system is bestowed with the ability to introduce heritable precision insertions and deletions in the eukaryotic genome. The combination of popularity and superior capabilities of CRISPR/Cas9 system raises the possibility that this technology may occupy the roles currently served by RNAi and may even make RNAi obsolete. We performed a comparative analysis of the technical aspects and applications of the CRISPR/Cas9 system and RNAi in mammalian systems, with the purpose of charting out a predictive picture on whether the CRISPR/Cas9 system will eclipse the existence and future of RNAi. -
Guide for Morpholino Users: Toward Therapeutics
Open Access Journal of Drug Discovery, Development and Delivery Special Article - Antisense Drug Research and Development Guide for Morpholino Users: Toward Therapeutics Moulton JD* Gene Tools, LLC, USA Abstract *Corresponding author: Moulton JD, Gene Tools, Morpholino oligos are uncharged molecules for blocking sites on RNA. They LLC, 1001 Summerton Way, Philomath, Oregon 97370, are specific, soluble, non-toxic, stable, and effective antisense reagents suitable USA for development as therapeutics and currently in clinical trials. They are very versatile, targeting a wide range of RNA targets for outcomes such as blocking Received: January 28, 2016; Accepted: April 29, 2016; translation, modifying splicing of pre-mRNA, inhibiting miRNA maturation and Published: May 03, 2016 activity, as well as less common biological targets and diagnostic applications. Solutions have been developed for delivery into a range of cultured cells, embryos and adult animals; with development of a non-toxic and effective system for systemic delivery, Morpholinos have potential for broad therapeutic development targeting pathogens and genetic disorders. Keywords: Splicing; Duchenne muscular dystrophy; Phosphorodiamidate morpholino oligos; Internal ribosome entry site; Nonsense-mediated decay Morpholinos: Research Applications, the transcript from miRNA regulation; Therapeutic Promise • Block regulatory proteins from binding to RNA, shifting Morpholino oligos bind to complementary sequences of RNA alternative splicing; and get in the way of processes. Morpholino oligos are commonly • Block association of RNAs with cytoskeletal motor protein used to prevent a particular protein from being made in an organism complexes, preventing RNA translocation; or cell culture. Morpholinos are not the only tool used for this: a protein’s synthesis can be inhibited by altering DNA to make a null • Inhibit poly-A tailing of pre-mRNA; mutant (called a gene knockout) or by interrupting processes on RNA • Trigger frame shifts at slippery sequences; (called a gene knockdown). -
Microrna: the Perfect Host
RESEARCH HIGHLIGHTS RNA INTEREFERENCE MicroRNA: the perfect host By creating an expression cassette that embeds the sequence of short hairpin (sh)RNA into the larger fold of a ubiq- uitous microRNA, scientists can achieve highly efficient target gene knockdown. ‘Let a cell teach you how to do RNA methods interference most effectively’, could have been the motto behind collaborative efforts by the groups of Greg Hannon and Scott 5' Lowe at Cold Spring Harbor Laboratory 3' .com/nature e and Stephen Elledge at Harvard University to generate a second generation of shRNA Figure 1 | Cells process a hairpin RNA (red) embedded in a microRNA fold like endogenous microRNAs. .natur The RNAi machinery of the cell cleaves the microRNA (at the sites indicated with arrows) leading to a w libraries. Their goal was to develop an effec- tive screening tool to identify genes essen- robust expression of small interfering RNAs. tial for the regulation of tumor growth; a http://ww previous shRNA expression library had given good results, but it suffered from small interfering RNAs (Fig. 1). Hannon tion of any shRNA into the microRNA oup sub-optimal efficiency of knockdown. and Elledge created large libraries of fold, together with a promoter of choice. r G The scientists adopted a strategy, first microRNA-based shRNA vectors targeting Although the Hannon-Elledge library introduced by Brian Cullen at Duke many of the human and mouse genes, and is driven by an RNA polymerase III pro- University, which takes advantage of observed more efficient knockdown than moter, a promoter the cell uses for small lishing the cell’s endogenous RNA interference with the previous shRNA library (Silva et noncoding RNAs, microRNAs—like b (RNAi) machinery to process and cleave an al., 2005). -
Artificial Microrna-Based RNA Interference and Specific Gene
agronomy Article Artificial microRNA-Based RNA Interference and Specific Gene Silencing for Developing Insect Resistance in Solanum lycopersicum Mohammad Faisal * , Eslam M. Abdel-Salam and Abdulrahman A. Alatar Department of Botany & Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia; [email protected] (E.M.A.-S.); [email protected] (A.A.A.) * Correspondence: [email protected]; Tel.: +966-(011)-4675877 Abstract: RNA Interference (RNAi), which works against invading nucleic acids or modulates the expression of endogenous genes, is a natural eukaryotic regulating system, and it works by noncoding smaller RNA molecules. Plant-mediated gene silencing through RNAi can be used to develop plants with insect tolerance at transcriptional or post-transcriptional levels. In this study, we selected Myzus persicae’s acetylcholinesterase 1 gene (Ace 1) as a silencing target to develop transgenic Solanum lycopersicum L. plants’ resistance to aphids. An RNAi plasmid vector containing an artificial microRNA (amiRNA) sequence was engineered and successfully transformed into Jamila and Tomaland, two elite tomato cultivars. A northern blot analysis and PCR were carried out to check the efficacy of Agrobacterium-mediated transformation in T0 transgenic plants. The quantitative PCR data showed a substantial downregulation of the Ace 1 gene in aphids fed in clip cages on T1 transgenic plants. Furthermore, there was a substantial drop in aphid colonies that were fed on T1 transgenic plants of both the cultivars. These findings strongly suggest that transgenic plants that express amiRNA could be an important tool for engineering plants resistant to aphids and possibly for the prevention of viral disease in other plant-infested pests. -
The Epigenetics of Non-Coding RNA
CHAPTER 4 The Epigenetics of Non-coding RNA Lesley J. Collins1, Barbara Schönfeld2,3, and Xiaowei Sylvia Chen4 1Massey Genome Service, Massey University, Palmerston North, New Zealand 2Allan Wilson Centre for Molecular Ecology and Evolution, Massey University, Palmerston North, New Zealand 3Institute of Molecular BioSciences, Massey University, Palmerston North, New Zealand 4Department of Biochemistry, University of Otago, Dunedin 9054, New Zealand INTRODUCTION Non-protein-coding RNAs (ncRNAs) are RNAs that are transcribed from DNA but are not translated into proteins. Many are functional and are involved in the processing and regulation of other RNAs such as mRNA, tRNA, and rRNA. Processing-type ncRNAs include small nuclear RNAs (snRNAs) involved in splicing, small nucleolar RNAs (snoRNAs) that 49 modify nucleotides in rRNAs and other RNAs, and RNase P that cleaves pre-tRNAs. Other small ncRNAs such as microRNAs (miRNAs) and short interfering RNAs (siRNAs) are involved in the regulation of target mRNAs and chromatin. Although many of these latter ncRNA classes are grouped under the term RNA interference (RNAi), it has become clear that there are many different ways that ncRNAs can interact with genes to up-regulate or down-regulate expression, to silence translation, or guide methylation [1–3]. Adding to these classes are long ncRNAs (typically 200 nt) that have also been implicated in gene regulation [4]. All of these ncRNAs form a network of processes, the RNA-infrastructure [2] that spans the cell not only spatially as RNAs move across the cell, but also temporally as the RNAs regulate gene processes during the cell cycle. Thus, the regulation of RNA processes may not only be transcriptional or translational, but also from their biogenesis and processing pathways [2]. -
Integrated Platform for Genome-Wide Screening and Construction of High
Integrated platform for genome-wide screening and PNAS PLUS construction of high-density genetic interaction maps in mammalian cells Martin Kampmanna,b, Michael C. Bassika,b, and Jonathan S. Weissmana,b,1 aDepartment of Cellular and Molecular Pharmacology, California Institute for Quantitative Biomedical Research and bHoward Hughes Medical Institute, University of California, San Francisco, CA 94158 Contributed by Jonathan S. Weissman, April 25, 2013 (sent for review February 23, 2013) A major challenge of the postgenomic era is to understand how function of another gene. In GI maps, GIs are determined for human genes function together in normal and disease states. In a large number of pairwise combinations of genes, and genes are microorganisms, high-density genetic interaction (GI) maps are clustered based on the similarity of their GI patterns. The clus- a powerful tool to elucidate gene functions and pathways. We tering typically reveals groups of genes that encode physically have developed an integrated methodology based on pooled interacting proteins or act in a common pathway (17). shRNA screening in mammalian cells for genome-wide identifica- In human cells, such a systematic elucidation of the functional tion of genes with relevant phenotypes and systematic mapping of interactions between human genes will be key to understanding all GIs among them. We recently demonstrated the potential of this how combinations of genes cause common polygenetic diseases approach in an application to pathways controlling the suscepti- and to developing -
RNA Interference Strategies for Future Management of Plant Pathogenic Fungi: Prospects and Challenges
plants Article RNA Interference Strategies for Future Management of Plant Pathogenic Fungi: Prospects and Challenges Daniel Endale Gebremichael 1, Zeraye Mehari Haile 1,2 , Francesca Negrini 1, Silvia Sabbadini 3 , Luca Capriotti 3, Bruno Mezzetti 3,4 and Elena Baraldi 1,* 1 Department of Agricultural and Food Sciences (DISTAL), University of Bologna, viale Fanin 44, 40126 Bologna, Italy; [email protected] (D.E.G.); [email protected] (Z.M.H.); [email protected] (F.N.) 2 Ethiopian Institute of Agricultural Research (EIAR), P.O. Box 2003, Addis Ababa 1000, Ethiopia 3 Department of Agricultural, Food and Environmental Sciences, Marche Polytechnic University, 60131 Ancona, Italy; [email protected] (S.S.); [email protected] (L.C.); [email protected] (B.M.) 4 Research Group on Food, Nutritional Biochemistry and Health, Universidad Europea del Atlántico, 39011 Santander, Spain * Correspondence: [email protected] Abstract: Plant pathogenic fungi are the largest group of disease-causing agents on crop plants and represent a persistent and significant threat to agriculture worldwide. Conventional approaches based on the use of pesticides raise social concern for the impact on the environment and human health and alternative control methods are urgently needed. The rapid improvement and extensive implementation of RNA interference (RNAi) technology for various model and non-model organisms Citation: Gebremichael, D.E.; Haile, has provided the initial framework to adapt this post-transcriptional gene silencing technology for Z.M.; Negrini, F.; Sabbadini, S.; the management of fungal pathogens. Recent studies showed that the exogenous application of Capriotti, L.; Mezzetti, B.; Baraldi, E.